About Ubicept
Ubicept is a private company based in Boston, Massachusetts, incorporated in 2021 in Delaware. It has reported $12,435,992 raised in two offerings on Form D since July 2023. Its chief executive is Sebastian Bauer.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 10, 2025 | Jun 24, 2025 | $4,620,993of $4.9M target | 9 | $513K | EquityRule 506(b) | Form D ↗ |
| May 16, 2023 | Jul 27, 2023 | $7,814,999fully sold | 16 | $488K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $12,435,992 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Ubicept's Form D filed Jun 24, 2025.
CD
Craig Dickman
Director
TS
Tristan Swedish
Executive officer and director
SB
Sebastian Bauer
Chief Executive Officer and director
Earlier filings also listed Sunil Nagaraj (director, last listed Jul 2023).